J Mov Disord.
2019 Sep;12(3):192-194. 10.14802/jmd.19022.
Benefits of Levodopa-Carbidopa Intestinal Gel Infusion in Patients with Parkinson's Disease Experiencing Gait Dysfunction Following Subthalamic Deep Brain Stimulation
- Affiliations
-
- 1Neurology Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia. thomas.kimber@sa.gov.au
- 2Department of Medicine, University of Adelaide, Adelaide, South Australia, Australia.
- KMID: 2464640
- DOI: http://doi.org/10.14802/jmd.19022
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Levodopa-induced respiratory dysfunction in Parkinson’s disease managed with subthalamic nucleus deep brain stimulation
- Subthalamic Deep Brain Stimulation for Parkinson's Disease
- Deep Brain Stimulation of the Subthalamic and Pedunculopontine Nucleus in a Patient with Parkinson's Disease
- Rescue Levodopa/Carbidopa Intestinal Gel for Secondary Deep Brain Stimulation Failure
- Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose
